article thumbnail

Could long Covid’s signs of immune dysregulation in the blood lead to a diagnostic test?

STAT

Not knowing what triggers its persistent and distressing symptoms makes the condition challenging to treat; it’s hard to even say definitively who has it. Long Covid has long eluded scientists looking for its cause.

article thumbnail

Vertex to acquire Alpine Immune Sciences for $4.9bn

Pharmafile

Vertex Pharmaceuticals and Alpine Immune Sciences have announced that they have entered into a definitive agreement under which Vertex will acquire Alpine for $65 per share, totaling an approximate $4.9bn. Alpine’s lead […] The post Vertex to acquire Alpine Immune Sciences for $4.9bn appeared first on Pharmafile.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

4th Antigen Specific Immune Tolerance Summit

pharmaphorum

The 4 th Antigen Specific Immune Tolerance Digital Summit (ASIT) brings together industry representatives from the fields of autoimmunity, allergy, immuno-oncology and transplantation to tackle the complexities behind autoimmune disorders head on. This is the industry’s definitive antigen specific drug development forum.

article thumbnail

STAT+: Study finds supplements of amino acid taurine slow aging in mice and monkeys

STAT

In a 1975 paper, published in Science , Hayes and his colleagues definitively established that taurine deficiency was to blame for retinal degeneration in cats, a landmark discovery that forever changed feline nutrition and eventually launched the Garfield-endorsed Alpo cat food. Continue to STAT+ to read the full story…

article thumbnail

Merck agrees to acquire Prometheus Biosciences for $10.8bn

Pharmaceutical Technology

Merck has signed a definitive agreement to buy clinical-stage biotechnology firm Prometheus Biosciences for $10.8bn, strengthening its immunology pipeline. Prometheus Biosciences uses precision medicine to discover, develop and commercialise new therapeutic and companion diagnostic products to treat immune-mediated diseases.

article thumbnail

9 health benefits of sweet potatoes

The Checkup by Singlecare

Lots of good-for-you foods get casually called “superfoods,” but if there’s one that definitely deserves the title, it’s the sweet potato. It’s important to note, though, that the way in which you eat sweet potatoes definitely plays a role here. They’re good for your immune system. They pack a nutritional punch. .

article thumbnail

Roche to acquire biopharma firm Good Therapeutics for $250m

Pharmaceutical Technology

Roche has signed a definitive merger agreement for the acquisition of US-based biopharmaceutical company Good Therapeutics for an upfront payment of $250m in cash. Good Therapeutics focuses on the development of PD-1-regulated IL-2 drugs that are based on innovative conditionally active drug technology.